Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inogen (INGN) Research & Development (2016 - 2026)

Inogen has reported Research & Development over the past 13 years, most recently at $5.3 million for Q4 2025.

  • Quarterly Research & Development fell 9.87% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.4 million through Dec 2025, down 10.23% year-over-year, with the annual reading at $19.4 million for FY2025, 10.23% down from the prior year.
  • Research & Development was $5.3 million for Q4 2025 at Inogen, up from $4.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $6.7 million in Q4 2023 and troughed at $3.5 million in Q3 2024.
  • The 5-year median for Research & Development is $5.0 million (2025), against an average of $5.0 million.
  • Year-over-year, Research & Development skyrocketed 47.08% in 2022 and then crashed 38.67% in 2025.
  • A 5-year view of Research & Development shows it stood at $4.7 million in 2021, then rose by 26.69% to $5.9 million in 2022, then rose by 13.14% to $6.7 million in 2023, then fell by 12.15% to $5.9 million in 2024, then dropped by 9.87% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's Research & Development are $5.3 million (Q4 2025), $4.8 million (Q3 2025), and $5.2 million (Q2 2025).